Kaleido Scope6h
UAB researchers uncover shared response to dominant commensal bacterial flagellin epitope in Crohn’s patients and healthy infants
Researchers identified that the dominant B cell epitope of Lachnospiraceae flagellins and the utilization of the flagellin ...
Ski great to retire aged 27 after Crohn's diagnosis
Jarl Magnus Riiber, the most successful Nordic combined athlete of all time, will retire at the end of the season aged 27 ...
Health on MSN5d
My First Signs of Crohn's Disease Weren't Digestion-Related: What To Look Out For
Fact checked by Nick Blackmer Crohn's disease can cause symptoms unrelated to your digestion. Health's Crohn's Disease ...
Too Old to Operate11h
Mediterranean Diet’s Impact on Crohn’s Disease Management
The following is a summary of “Mechanistic implications of the Mediterranean diet in patients with newly diagnosed Crohn's disease- multi-omic results from a prospective cohort,” published in the ...
Pharm Exec1d
Treating Disruptive Symptom’s in Crohn’s Patients: Q&A with Mark Genovese, MD
Mark Genovese: Crohn’s disease is a chronic, inflammatory bowel disease associated with progressive bowel damage, disability, ...
New bowel cancer test has ‘90% accuracy’ at predicting disease in those at high risk – without invasive procedures
A NEW method for detecting bowel cancer is more than 90 per cent accurate at predicting which higher risk people will develop ...
Ibj.com1d
Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
Algorithm study 90% accurate predicting bowel cancer
The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.
NHS warns symptom which shows on leg could be common disease
The NHS is urging people to go to their GP if they have a key symptom that can appear anywhere on the body, but more notably, ...
The American Journal of Managed Care6d
FDA Approves Mirikizumab for Crohn Disease
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
Jewish Press1d
Targeted mRNA Therapy Holds Promise for Crohn’s Disease, Colitis, and Beyond
The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.
FDA approves Omvoh for moderately to severely active Crohn's disease
The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...